Daniel Nicholas Heintz

Title: Innovations of Daniel Nicholas Heintz

Introduction

Daniel Nicholas Heintz is an accomplished inventor based in St. Louis, MO. He has made significant contributions to the field of biotechnology, particularly in the development of injectable formulations. With a total of 3 patents to his name, Heintz continues to push the boundaries of innovation in his area of expertise.

Latest Patents

One of Heintz's latest patents is focused on a non-aqueous injectable formulation preparation with pH adjusted for the extended release of somatotropin. This invention provides compositions that allow for the extended release and enhanced bioavailability of biologically-active polypeptides following parenteral delivery to an animal. The compositions comprise somatotropin, a pH-adjusting constituent (PAC), and a substantially non-aqueous, hydrophobic excipient. The PAC may include biocompatible compounds such as acetic acid, phosphoric acid, and monobasic phosphate. This innovative formulation aims to adjust the pH to or near the isoelectric point of the somatotropin component, thereby improving its effectiveness.

Career Highlights

Heintz is currently associated with Monsanto Technology LLC, where he applies his expertise in biotechnology to develop cutting-edge solutions. His work has been instrumental in advancing the field and improving the delivery mechanisms of biologically-active compounds.

Collaborations

Heintz collaborates with notable professionals in his field, including his coworker Yunhua N Jeng. These collaborations enhance the innovative potential of their projects and contribute to the success of their research endeavors.

Conclusion

Daniel Nicholas Heintz is a prominent inventor whose work in injectable formulations has the potential to revolutionize the delivery of biologically-active compounds. His contributions to biotechnology are noteworthy, and his ongoing innovations will likely have a lasting impact on the industry.